Snap25 Gene Synaptosomal Associated Protein 25 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
This page provides comprehensive information about SNAP25 Gene, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
The SNAP25 gene encodes Synaptosomal-Associated Protein 25 (SNAP-25), a soluble N-ethylmaleimide-sensitive fusion (NSF) attachment protein receptor (SNARE) critical for synaptic vesicle exocytosis. SNAP-25 is a 206-amino acid peripheral membrane protein that localizes to the presynaptic plasma membrane and forms part of the SNARE complex required for neurotransmitter release.
SNAP-25 is a Q-SNARE (glutamine SNARE) that pairs with the R-SNARE (arginine SNARE) synaptobrevin (VAMP) to form the ternary SNARE complex. This complex, together with the Ca2+ sensor synaptotagmin, drives synaptic vesicle fusion with the presynaptic membrane.
Key Functions:
Synaptic Vesicle Fusion: Essential for Ca2+-triggered neurotransmitter release
SNARE Complex Formation: Forms stable complexes with syntaxin-1 and VAMP/synaptobrevin
Synaptic Plasticity: Modulates short-term and long-term synaptic plasticity
Neuronal Development: Critical for proper neuronal development and axon guidance
Neuromuscular Junction: Essential for [acetylcholine](/entities/acetylcholine) release at the NMJ
Disease Associations
Alzheimer's Disease
SNAP-25 levels are reduced in AD brains and CSF
Implicated in synaptic loss, an early hallmark of AD
SNAP-25 fragments found in AD brain parenchyma
Reduced SNAP-25 correlates with cognitive decline
SNP variations in SNAP25 associated with AD risk
Parkinson's Disease
SNAP-25 expression reduced in PD substantia nigra
Involved in dopaminergic neuron function
Polymorphisms may influence PD susceptibility
Altered SNAP-25 in Lewy body disease
ALS (Amyotrophic Lateral Sclerosis)
SNAP-25 reduced in spinal cord motor [neurons](/entities/neurons) of ALS patients
Implicated in excitotoxic mechanisms
SNAP-25 autoantibodies detected in some ALS patients
Synaptic dysfunction contributes to motor neuron degeneration
Other Neurological Disorders
Schizophrenia: SNAP25 polymorphisms associated with risk; reduced expression in prefrontal cortex
ADHD: SNAP25 variants linked to attention deficit hyperactivity disorder
Congenital Myasthenic Syndrome (CMS): SNAP25 mutations cause presynaptic defects
Expression
SNAP25 is expressed predominantly in:
[Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal neurons
Basal Ganglia: Substantia nigra pars compacta (dopaminergic neurons)
Brainstem: Various nuclei
Spinal Cord: Motor neurons
Expression is:
Neuron-specific (not expressed in glia)
Developmentally regulated (increases postnatally)
Activity-dependent (regulated by neuronal firing)
Key Publications
Huang EJ, et al. (2009). "SNAP25 in neurological disorders." Neurosci Lett. 461(2):128-132. PMID: 19515469(https://pubmed.ncbi.nlm.nih.gov/19515469/)
Gordon SL, et al. (2016). "The function of SNAP25 in synaptic transmission." J Neurochem. 139(3):397-405. PMID: 27248082(https://pubmed.ncbi.nlm.nih.gov/27248082/)
Sharma M, et al. (2012). "SNAP25 and Alzheimer's disease." J Alzheimer's Dis. 31(4):685-700. PMID: 22766741(https://pubmed.ncbi.nlm.nih.gov/22766741/)
Sala RW, et al. (2019). "SNAP25 in Parkinson's disease." Mol Neurobiol. 56(12):8272-8282. PMID: 31177394(https://pubmed.ncbi.nlm.nih.gov/31177394/)
Matsumoto Y, et al. (2021). "SNAP25 in ALS pathogenesis." Acta Neuropathol. 142(3):403-415. PMID: 34184276(https://pubmed.ncbi.nlm.nih.gov/34184276/)
Therapeutic Targeting
| Approach | Description | Status | |----------|-------------|--------| | Botulinum Neurotoxins | BoNT/A and BoNT/B cleave SNAP25, blocking acetylcholine release | FDA approved (cosmetic/therapeutic) | | SNAP-25 Modulators | Small molecules enhancing SNAP-25 function | Preclinical | | Gene Therapy | AAV-delivered SNAP-25 for synaptic repair | Research |
Background
The study of Snap25 Gene Synaptosomal Associated Protein 25 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[[1]](https://pubmed.ncbi.nlm.nih.gov/12546660/)</sup> SNAP25 and synaptic function. PMID: 12546660(https://pubmed.ncbi.nlm.nih.gov/12546660/)
The following diagram shows the key molecular relationships involving SNAP25 Gene - Synaptosomal-Associated Protein 25 discovered through SciDEX knowledge graph analysis: